Screener / SEC EDGAR /CIK 0001005284 /10-K filed Feb 19, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Electronic Components

Universal Display Corp \PA\ OLED

Compare with peers Embed
The 10-K against last year's

41 changes: 1 added, 40 reworded

10-K Feb 19, 2026 vs Feb 20, 2025

10-K 0001193125-26-059371 (Feb 19, 2026) vs 10-K 0000950170-25-024151 (Feb 20, 2025) Not compared: Accounting Policies.

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

106 paragraphs · 1 new · 6 reworded · 0 gone · 10-K Feb 19, 2026 against Feb 20, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 100 · 25% changed Every version of it
With respect to material sales, our sales are primarily dependent on purchases made by a relatively small number of customers. In addition to the other factors described above relating to our customers’ sales opportunities, our quarter-to-quarter sales may be materially impacted by our customers’ inventory management plans, which may vary substantially based on financial management considerations, changes in their product mix plans, modified material processing techniques and manufacturing line modifications.
Paragraph 64 · 20% changed Every version of it
Increases in prices, including as a result of inflation and rising interest rates, for raw materials or other inputs that we and our suppliers use in manufacturing our OLED materials, or increases in logistics and related costs, have led and may continue to lead to higher production costs for our materials. In addition, any increase in the cost or reduced availability of critical materials for our OLED materials could lead to higher production costs. Further, uncertain supply of such materials could disrupt our or our suppliers’ ability to obtain such materials in a timely manner and/or could lead to increased costs. Geopolitical risks and crises, fluctuations in supply and demand, fluctuations in interest rates, any weakening of the U.S. dollar, and other economic and political factors have created and may continue to create pricing pressure for raw materials and other inputs. These inflationary pressures could, in turn, negatively impact our profitability because we may not be able to pass these costs on to our customers or require our suppliers to absorb such costs.
Paragraph 54 · 16% changed Every version of it
Heightened levels of inflation on critical raw material and labor costs and the potential worsening of macro-economic conditions, including slower growth or recession, changes to fiscal and monetary policy, tighter credit, higher interest rates and currency fluctuations, present a risk for us, our suppliers and the display and lighting industries in general. If inflation on critical raw materials and labor remains at current levels for an extended period, or increases, and we are unable to successfully mitigate the impact, our costs are likely to increase, resulting in pressure on our profits, margins and cash flows, particularly for existing fixed-price contracts. In addition, our business could be adversely impacted if our customers experience budget, inflationary or other pressures, such as increases in the cost of borrowing from rising interest rates.
Paragraph 42 · 10% changed Every version of it
The display market remains dominated by displays based on LCD technology. Numerous companies are making substantial investments in, and conducting research to improve characteristics of, LCDs; additionally, other in competing display technologies have been, or are being, developed, like technologies, such as LCD and microLED. A similar situation exists in the solid-state lighting market, which is currently dominated by LED products. Advances in any of these various technologies may overcome their current limitations and permit them to become the leading technologies in their field, either of which could limit the potential market for products utilizing our OLED technologies and materials. This, in turn, would cause product manufacturers to avoid entering into commercial relationships with us, or to terminate or not renew their existing relationships with us.

MD&A

57 paragraphs · 0 new · 26 reworded · 0 gone · 10-K Feb 19, 2026 against Feb 20, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 37 · 46% changed
Revenue from royalty and license fees was $275.1 million for the year ended December 31, 2025 as compared to $266.8 million for the year ended December 31, 2024 as compared to $238.4 million for the year ended December 31, 2023, 2024, an increase of 12%. 3%. The increase in royalty and license fees was primarily the result of higher unit material volume and changes in customer mix. mix, partially offset by a $7.1 million reduction in revenue due to an out of period adjustment. The out of period adjustment was due to a correction of an error that originated during the third quarter of 2023. We have evaluated the impacts of this error, both quantitatively and qualitatively, and have concluded that the error was not material to the Consolidated Financial Statements for any interim or annual period prior to the three months ended September 30, 2025, nor was it material to the full year ended December 31, 2025.
Paragraph 42 · 44% changed
Selling, general and administrative expenses increased to was $74.3 million for each of the year years ended December 31, 2024, as compared to $67.4 million for the year ended December 31, 2023. The increase in selling, general 2025 and administrative expenses was primarily due to an increase in employee-related expenses, including higher salaries expenses and stock-based compensation. 2024.
Paragraph 41 · 32% changed
Research and development expenses increased decreased to $146.1 million for the year ended December 31, 2025, as compared to $157.2 million for the year ended December 31, 2024, as compared to $130.5 million for the year ended December 31, 2023. 2024. The increase decrease in research and development expenses was primarily due to an increase in PPG development activity, including new product development restructuring costs and commencement closure of development activities in Shannon, Ireland, and the OVJP Corp reorganization expenses. As a result of the planned closure of OVJP Corp's facility in California location, we recorded $8.9 million of restructuring costs for the year ended during December 31, 2024.
Paragraph 18 · 30% changed
In February 2021, we announced the establishment of a new manufacturing site in Shannon, Ireland and an agreement between UDC Ireland Limited and PPG for the production of our OLED materials. We The Shannon manufacturing facility became operational in June 2022 and we purchased the site during September 2023. When fully operational, the new The Shannon manufacturing facility is expected provides incremental manufacturing capacity to double meet our expanding production capacity needs, and allow allows for the geographical diversification of our manufacturing base for phosphorescent emitters. The first phase the world-wide distribution of facility improvements has been completed and operations commenced in June 2022. our materials
Paragraph 44 · 30% changed
Patent costs decreased increased to $8.8 million for the year ended December 31, 2025, as compared to $8.7 million for the year ended December 31, 2024, as compared to $9.4 million for the year ended December 31, 2023. The results in the current year reflected lower internal prosecution related costs. 2024.
Paragraph 32 · 30% changed
During the year ended December 31, 2024, 2025, based on our previous earnings history, a current evaluation of expected future taxable income and other evidence, we determined to retain the valuation allowance that relates to New Jersey research and development credits and unrealized loss on investments. credits. In addition, a portion of the investment loss was realized resulting in a Company has an unrealized gain on investments that if sold, could offset the capital loss carryforward that is not more likely than not to be used within the carryforward period. As such, we provided a such the valuation allowance against on the capital loss. loss was reversed. There are no indicators against the realizability of the remaining net deferred net-deferred tax assets. Actual results could differ from our assessments if adequate taxable income is generated in future periods. To the extent we establish a new valuation allowance or change a previously established valuation allowance in a future period, income tax expense will be impacted.
Paragraph 11 · 29% changed
In 2015, we entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display Co., Ltd. (LG Display). The In 2021, we and LG Display entered into new agreements that extended the terms of these agreements have been extended at least through the end of 2025. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under our their patent portfolio. The patent license calls for minimum annual license fees, prepaid royalties fees and running royalties additional incremental license fees based on LG Display’s volume of sale of licensed products. The OLED commercial supply agreement provides for the sales sale of dopant and host materials for use by LG Display, which may include phosphorescent emitters and host materials. The agreements provide for certain other minimum obligations relating to the volume of material sales anticipated over the life of the agreements as well as minimum royalty revenue. Display.
Paragraph 43 · 26% changed
Amortization of acquired technology and other intangible assets was $18.2 million for each of the year years ended December 31, 2024, as compared to $16.0 million for the year ended December 31, 2023. The increase was due to the commencement of amortization expense associated with the Merck KGaA patent acquisition that was completed in April 2023. 2025 and 2024. See Note 7 in Notes to Consolidated Financial Statements for further discussion.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 4 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

MD&A108 words changed in this paragraph; it is 56% similar to last year's version.
Interest income, net was $39.7 million for the year ended December 31, 2025, as compared to $40.7 million for the year ended December 31, 2024. Other income (loss), net primarily consisted of net exchange gains and losses on foreign currency transactions, net investment gains and losses, and rental income. We recorded other income, net of $6.5 million for the year ended December 31, 2025 as compared to other loss, net of $7.4 million for the year ended December 31, 2024 as compared to $184,000 for the year ended December 31, 2023. 2024. The increase in other loss, income (loss), net during the year ended December 31, 2024 2025 was primarily due to a $3.9 million investment gain, net on our marketable equity securities portfolio and a $935,000 foreign exchange gain during the year ended December 31, 2025 as compared to a $7.2 million foreign exchange loss that was during the year ended December 31, 2024. Net exchange gains and losses on foreign currency are primarily caused by the fluctuation in the Korean Won to the U.S. Dollar exchange rate and resulting remeasurement of a Korean Won-denominated withholding tax receivable.

Source: Item 7, 10-K 0001193125-26-059371 vs Item 7, 10-K 0000950170-25-024151

Risk Factors85 words changed in this paragraph; it is 67% similar to last year's version.
Increases in prices, including as a result of inflation and rising interest rates, for raw materials or other inputs that we and our suppliers use in manufacturing our OLED materials, or increases in logistics and related costs, have led and may continue to lead to higher production costs for our materials. In addition, any increase in the cost or reduced availability of critical materials for our OLED materials could lead to higher production costs. Further, uncertain supply of such materials could disrupt our or our suppliers’ ability to obtain such materials in a timely manner and/or could lead to increased costs. Geopolitical risks and crises, fluctuations in supply and demand, fluctuations in interest rates, any weakening of the U.S. dollar, and other economic and political factors have created and may continue to create pricing pressure for raw materials and other inputs. These inflationary pressures could, in turn, negatively impact our profitability because we may not be able to pass these costs on to our customers or require our suppliers to absorb such costs.

Source: Item 1A, 10-K 0001193125-26-059371 vs Item 1A, 10-K 0000950170-25-024151

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of OLED's Risk Factors and MD&A, 10-K Feb 19, 2026 against 10-K Feb 20, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
In addition, our business could be adversely impacted if our customers experience budget, inflationary or other pressures, such as increases in the cost of borrowing from rising interest rates. Increases in interest rates may have a particularly pronounced impact on highly leveraged customers located in the Asia-Pacific region. These customers may face greater challenges in servicing debt and maintaining liquidity in a rising rate environment, which could negatively affect their ability to invest in and commercialize products that utilize our OLED technologies and materials. As a result, financial strain on these key customers could reduce demand for our products and adversely affect our business and operating results.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedRisk Factors
In addition to the other factors described above relating to our customers’ sales opportunities, our quarter-to-quarter sales may be materially impacted by our customers’ inventory management plans, which may vary substantially based on financial management considerations, changes in their product mix plans, modified material processing techniques and manufacturing line modifications.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedRisk Factors
Heightened levels of inflation on critical raw material and labor costs and the potential worsening of macro-economic conditions, including slower growth or recession, changes to fiscal and monetary policy, tighter credit, higher interest rates and currency fluctuations, present a risk for us, our suppliers and the display and lighting industries in general.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedRisk Factors
If inflation on critical raw materials and labor remains at current levels for an extended period, or increases, and we are unable to successfully mitigate the impact, our costs are likely to increase, resulting in pressure on our profits, margins and cash flows, particularly for existing fixed-price contracts.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
Changes in our operating assets and liabilities related to an increase in inventory of $58.0 million, an increase in other assets of $26.2 $27.0 million, a decrease in deferred revenue of $26.1 million, $10.7 million and an increase in inventory accounts receivable of $7.2 million and a decrease in other liabilities of $2.4 $6.3 million, partially offset by a decrease in accounts receivable of $26.2 million and an increase in accounts payable and accrued expenses of $10.4 million. $2.1 million and an increase in other liabilities of $248,000.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
The increase decrease was due to the timing of maturities and purchases of investments resulting in net sales and maturities of $20.9 million for the year ended December 31, 2025, as compared to net purchases of $121.8 million for the year ended December 31, 2024, as compared to net sales and maturities of $43.1 million for the year ended December 31, 2023, partially offset by a decrease an increase in purchases of intangibles and property and equipment of $83.7 $23.8 million.
Read it in 10-K Feb 19, 2026 at sec.gov
Show the other 10
RewordedMD&A
The increase in property property, plant and equipment and intangibles purchases during the year ended December 31, 2023 2025 was primarily due to the Merck KGaA patent acquisition and the purchases continued expansion of the Shannon manufacturing facility in Shannon, Ireland and the South Korea application center. improvements to our research and development facility in Ewing, New Jersey.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
Our total material sales were $353.0 million for the year ended December 31, 2025, as compared to $365.4 million for the year ended December 31, 2024, as compared to $322.0 million for the year ended December 31, 2023, an increase a decrease of 13% 3% with an increase a commensurate decrease in unit material volume of 15%. 1%.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
As a result of the increase decrease in revenue from material sales and sales, partially offset by the increases in revenue from royalty and license fees, fees and contract research, gross margin for the year ended December 31, 2024 increased 2025 decreased by $58.2 $2.7 million as compared to the year ended December 31, 2023, 2024, with gross margin as a percentage of revenue remaining consistent at decreasing to 76% from 77%.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
Contract research services revenue was $22.5 million for the year ended December 31, 2025 as compared to $15.4 million for the year ended December 31, 2024 as compared to $16.0 million for the year ended December 31, 2023, a decrease 2024, an increase of 4%. 46%.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
When fully operational, the new The Shannon manufacturing facility is expected provides incremental manufacturing capacity to double meet our expanding production capacity needs, and allow allows for the geographical diversification of our manufacturing base for phosphorescent emitters. the world-wide distribution of our materials
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
Cost of sales for the year ended December 31, 2024 2025 increased by $13.1 $5.7 million as compared to the year ended December 31, 2023, 2024, primarily due to an increase in the level Adesis' cost of material sales and changes in product mix, partially offset by a $5.4 million decrease in inventory reserve expense. mix.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
Revenue from royalty and license fees was $275.1 million for the year ended December 31, 2025 as compared to $266.8 million for the year ended December 31, 2024 as compared to $238.4 million for the year ended December 31, 2023, 2024, an increase of 12%. 3%.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
Research and development expenses increased decreased to $146.1 million for the year ended December 31, 2025, as compared to $157.2 million for the year ended December 31, 2024, as compared to $130.5 million for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
The cumulative catch-up adjustment recorded to revenue arising from changes in estimates of transaction price, net was $14.1 million for the year ended December 31, 2025 as compared to $10.8 million for the year ended December 31, 2024 as compared to $10.6 million for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 19, 2026 at sec.gov
RewordedMD&A
Royalty and license expense increased decreased to $504,000 for the year ended December 31, 2025, as compared to $2.0 million for the year ended December 31, 2024, as compared to $647,000 for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 19, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OLED/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.